Skip to content

Clinical trials

Observational Thrombocythemia, Essential trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Observational Country / region: China Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China1
Nanfang Hospital, Southern Medical University1
Shandong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential3
Anemia, Aplastic1
Anemia, Hemolytic, Autoimmune1
Hemoglobinuria, Paroxysmal1
Hemophilia A1
Hemophilia B1
Hemostatic Disorders1
Leukemia1
Leukemia, Large Granular Lymphocytic1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.